Semiconductor pain drove the equity story this week — and researchers spent seven days debating whether it's a healthy rotation or the start of something worse.
The SOX slid into correction, with one analysis pegging it down 17% on the month. Several published views framed this as overdue: stretched valuations, unsustainable capex growth funded by dilutive equity, and concentration risk in the S&P 500 reminiscent of prior bubbles. One note flagged Oracle's credit downgrade tied to OpenAI exposure as a symptom of the broader AI financing stretch.
But the read wasn't uniformly bearish. Other research argued earnings breadth is improving beyond megacap tech, pointing to strong bank results, healthcare leaders, and the equal-weight S&P outperforming. Value, staples, and energy were highlighted as rotation beneficiaries, with energy also lifted by Middle East risk. A long-term overweight on US large caps was reiterated despite froth.
Late in the week, sentiment leaned more cautious: multiple analysts warned a 5–10% pullback could unfold, with China's new open-source AI release cited as a fresh competitive threat to US tech leadership.